Concepedia
Statistics
Publications
7
Citations
124
H-Index
Active since
2019
Affiliations
AstraZeneca (Canada)(Current)
William Osler Health System
University Health Network
Princess Margaret Cancer Centre
Guangdong Provincial People's Hospital
Daniel Moldaver is an author at AstraZeneca (Canada) specializing in radiation oncology, medicine, and oncology.
Top concepts
MedicineOncologyRadiation OncologyHealthPathologyHematologyLung CancerHealth PolicyCancer GeneticsCancer Research
Publications per year
2019–2023
Real-World Treatment Patterns, Clinical Outcomes, and Health Care Resource Utilization in Extensive-Stage Small Cell Lung Cancer in Canada
Dylan E. O’Sullivan, Winson Y. Cheung, Iqra Syed et al. · Current Oncology · 2021 · 35 citations · Full text
1165P Modelling long-term survival outcomes in patients with stage (stg) IB–IIIA EGFR-mutated NSCLC from the ADAURA trial
Parneet Cheema, B. Heeg, M Dyer et al. · Annals of Oncology · 2021 · 17 citations
Development, validation and results from the impact of treatment evolution in non-small cell lung cancer (iTEN) model
Daniel Moldaver, M. Hurry, William K. Evans et al. · Lung Cancer · 2019 · 15 citations · Full text
EGFR mutation prevalence, real-world treatment patterns, and outcomes among patients with resected, early-stage, non-small cell lung cancer in Canada
M. Sara Kuruvilla, Geoffrey Liu, Iqra Syed et al. · Lung Cancer · 2022 · 15 citations
Egfr Mutation Prevalence, Surgical Oncology, Medicine +8
Evaluation of Cost-Effectiveness of Adjuvant Osimertinib in Patients with Resected EGFR Mutation-Positive Non-small Cell Lung Cancer
Andre Verhoek, Parneet Cheema, Barbara Melosky et al. · PharmacoEconomics - Open · 2023 · 15 citations · Full text
1–5 of 7